Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689 We conducted an assessor-masked, multicenter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results